Abstract:OBJECTIVE:To investigate the clinical characteristics, the medicine application and to evaluate the disease activity in patients with osteoarthritis (OA) in China.METHODS:This was a cross-sectional study. Totally 1 066 cases of OA from 40 hospitals in China from April to October 2017 were retrospectively enrolled. Demographic characteristics, clinical data, medicine application, and joint function were evaluated. All the data were analyzed by SPSS software 19.0. t test, Mann-Whitney U test and chi-square test were used for statistical analysis.RESULTS:In the 1 066 cases, the male-to-female ratio was 1:3.6 and the average age was (61.9±11.0) years, with an age range from 36 to 94 years. The incidence of knee OA, hip OA, and hand OA were respectively 81.9% (873/1 066), 14.1% (150/1 066), and 36.3% (387/1 066). In the study, 242 (22.7%) cases had two kinds of joint areas involved and three joint areas were involved in 51 cases (4.8%), and 56.6% (603/1 066) of the patients used more than one kind of non-steroid anti-inflammatory drugs (NSAIDs) while 61.2% (652/1 066) used disease modifying osteoarthritis drugs (DMOADs), including glucosamine (37.5%, 400/1 066), chondroitin sulfate (2.0%, 21/1 066), diacetate (5.9%, 63/1 066), and the combination of these drugs (15.8%, 168/1 066). 8.6% (92/1 066) patients only took analgesics to relieve the pain, not using any kind of NSAIDs or DMOADs. And 232 patients (21.7%) had intra-articular injections, including 9.2% (98/1 066) sodium hyaluronate, 4.5%(48/1 066) glucocorticoid, and 8.1% (86/1 066) combination of the two drugs. The proportion of the patients taking topical drugs accounted for 26.5% (283/1 066) and physical therapy accounted for 15.8% (168/1 066). Compared with those who suffered from knee OA, the patients who suffered from hip OA had more severe disease assessment. Moreover, there were significant differences in pain (Z=-7.625, P<0.001), morning stiffness (Z=-6.229, P<0.001), and joint function (Z=-6.777, P<0.001) between the two groups of the patients who suffered from knee or hip OA with The Western Ontario and McMaster Universities (WOMAC) osteoarthritis index. Furthermore, patients with hip OA took more analgesics (χ2=24.838, P<0.001).CONCLUSION:Oral NSAIDs and DMOADs are wildly used in patients with OA in China. However, the treatment of some patients still need to be improved. Patients with hip OA are more seriously ill and require aggressive treatment.

Clinical practice guideline for pain management of osteoarthritis in China: interpretation and application recommendations

Guidelines for the diagnosis and treatment of osteoarthritis in China (2019 edition)

Surgical management of osteoarthritis of the knee: evidence-based clinical practice guideline methodological interpretation and recommendations explanation

[Exploration on developing the diagnosis and treatment guidelines for osteoarthritis in primary care of China]

[Progress in Methodological Characteristics of Clinical Practice Guideline for Osteoarthritis].

Impact of a Clinical Pharmacist-Led Guidance Team on Cancer Pain Therapy in China: a Prospective Multicenter Cohort Study.

A Protocol for Developing a Clinical Practice Guideline for Intra-Articular Injection for Treating Knee Osteoarthritis

Chinese guidelines for the rehabilitation treatment of knee osteoarthritis: An CSPMR evidence-based practice guideline

Survey of Chinese orthopedists' cognition on the Chinese Osteoarthritis Guideline (2018 Edition)

[Clinical Significance of Arthritis Treatment Guidelines Revealed by Outpatients Prescriptions].

[Consensus on clinical drug therapy for knee osteoarthritis in China (2023)]

2021 revised algorithm for the management of knee osteoarthritis-the Chinese viewpoint

Strategies of osteoarthritis guidelines in clinical application

Development of clinical practice guidelines in 11 common diseases with Chinese medicine interventions in China

Quality assessment of Chinese clinical practice guidelines in orthopedics

[Interpretation of a clinical practice guideline on the management of chronic pain associated with temporomandibular joint disorders]

Expert Consensus of Chinese Association for the Study of Pain on the Non-Opioid Analgesics for Chronic Musculoskeletal Pain

[A Multi-Center Cross-Sectional Survey of Medicine Application in Patients with Osteoarthritis in China].

Osteoporosis guidelines on TCM drug therapies: a systematic quality evaluation and content analysis

A Brief Analysis of Clinical Best Practice Guidelines: Assessment and Management of Pain (third Edition) by Registered Nurses' Association of Ontario in 2013

Executive Summary: Clinical Practice Guideline of Chronic Kidney Disease – Mineral and Bone Disorder (CKD-MBD) in China